Some Xconomy San Diego Predictions for 2013

Editor’s note: As a New Year’s exercise, we asked a select group of Xconomists to answer this question: “What does your gut tell you will happen in 2013, even though you don’t have data to prove it?

Here’s a sampling from several San Diego Xconomists:

Ramesh Rao: Surreptitious behavioral data gathering and the appearance of more and more applications that aggregate more data than they will share back with the user.

Joe Panetta: My gut tells me that Washington will drag the fiscal cliff negotiations into the next Congressional session, and that it will cause more stock market uncertainty. Once things are settled and some stability sets in, we’ll see a new wave of life science financings, even a few IPOs.

Company expansion in California will be negatively impacted with the passage of Proposition 30, which asked voters to increase the personal income tax on individuals who make $250,000 a year and more.

I also predict that Peggy Hamburg will remain in place as FDA Commissioner, and that that will result in continued improvement in the review and approval track record for drugs and devices. I also see the EU continuing to experience economic uncertainty, especially given the recent resignation announcement by Italian Premier Mario Monti.

Duane Roth: I think there will be meaningful progress on addressing some of the budget and debt issues in Sacramento and Washington. David Fransen, the Canadian government’s Consul General in Los Angeles, pointed out recently at the Connect Global Summit that it was the liberal party in Canada that finally addressed their budget challenges in the ’90s. I hope we see the same here.

(Feel free to add your own predictions in our comment section, and best wishes for the New Year from Xconomy.)

Bruce V. Bigelow was the editor of Xconomy San Diego from 2008 to 2018. Read more about his life and work here. Follow @bvbigelow

Trending on Xconomy